Al Mojil Drug Company proudly participated in the 3rd Headache Day Conference

Al Mojil Drug Company proudly participated in the 3rd Headache Day Conference, in association with the Kuwait Neurology Society and chaired by Dr. Jassim Al Hashel, held on 24 January 2026 at the Regency Hotel, Kuwait.
Migraine is a highly disabling neurological disease that profoundly impacts patients’ quality of life and daily functioning, Addressing its burden requires sustained partnership, education, and innovation principles.
Reinforcing Al Mojil Drug Company’s long-standing commitment to medical education and improved patient outcomes.
We look forward to strengthening partnerships and advancing future initiatives that support innovation and excellence in healthcare